Discover the study supports the potential of neoadjuvant androgen deprivation therapy as an adjunctive therapy in HRLPC.

Prostate cancer is a health issue that impacts individuals worldwide, and choosing the best treatment can be difficult, given ...

The addition of Truqap to standard-of-care therapy improved radiographic progression-free survival in patients with ...

New consensus recommendations address implementation of novel treatments and imaging techniques for advanced and ...

Researchers conducted a retrospective study using data from 182 subjects with high-risk recurrent prostate cancers.

Evan Y. Yu, MD, discusses how systemic therapy options for newly diagnosed metastatic hormone-sensitive prostate cancer ...

Although treatments like androgen deprivation therapy have been effective for early-stage prostate cancer, advanced stages, such as castration-resistant prostate cancer, present significant ...

An auto-recruit program improved DXA screening and bone health management in men with prostate cancer receiving androgen-deprivation therapy.

Orion's collaboration partner Bayer has submitted an application to the Center of Drug Evaluation (CDE) of China's National ...

During an in-person Community Case Forum event in Miami, Florida, Mike Cusnir, MD, discussed the ARANOTE study outcomes ...

Researchers conducted a post hoc, retrospective, cross-sectional analysis of 182 patients with recurrent prostate cancer ...